OHI shorts trim back but stay elevated ahead of Monday's print

Omega Healthcare Investors enters Monday's Q3 earnings release with short sellers sitting on a position that grew sharply through October but pulled back noticeably in the past week.

Short interest fell about 4.6% over the seven days to October 29, bringing the count to roughly 15 million shares, equal to 5.1% of the free float. That retreat follows a 14% build over the past month, most of which landed in a single step around October 9. The official FINRA settlement figure puts days to cover at 7.6, still one of the higher readings across the healthcare REIT peer group. Borrow costs ticked up 7% on the week to 0.44% annually, but remain firmly in low-cost territory. Availability is extremely loose at 3,011%, meaning the lending pool holds roughly 30 times more shares than are currently borrowed. There is no stress in the borrow market. The stock added 1.6% on the week to close at $46.98, outpacing a median gain of roughly 0.4% for its closest peers including SBRA, VTR and NHI.

The analyst community remains divided on how much that stock gain is warranted. The consensus sits at Hold, with a mean price target of $51.37, roughly 9% above the current price. Citizens upgraded to Market Outperform on October 22. Wells Fargo trimmed its target to $46 from $48 nine days ago, holding Equal-Weight. UBS and Barclays both cut targets earlier in the month while keeping their existing ratings intact. The bull case rests on improving operator coverage ratios, active capital deployment into skilled nursing facilities, and a forward yield above 5.8%. Bears point to the unpredictable SNF reimbursement environment, reliance on third-party operators, and residual earnings dilution from the CommuniCare portfolio sale. EPS surprise ranks in the 94th percentile against the broader market, and the 30-day and 90-day EPS momentum scores are also strong, which gives the bull case some quantitative support.

Options positioning has eased slightly from recent highs. The put/call ratio came in at 1.31 on Thursday, just below its 20-day average of 1.35 and slightly less defensive than the elevated readings seen mid-October. That is consistent with a market that has priced in caution without adding fresh downside protection into the final days before the release.

Monday's print will test whether operator performance and acquisition activity can justify a stock trading at roughly 21.8 times earnings, against a backdrop where most analysts have been trimming rather than raising their numbers.